Investigational Site Number : 1560013

Tianjin 300211

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Breast Cancer Metastatic

Studies at this site

• Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Running, not enrolling
• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early